The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer

NCT06235164 · clinicaltrials.gov ↗

UNKNOWN

Status

585

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Gastric Cancer

Interventions

DRUG: immune checkpoint inhibitors: sintilimab, nivolumab, and camrelizumab

Sponsor

Fujian Medical University